Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

74.6K
Overview
74.6K
Tissue Transplantation01:24

Tissue Transplantation

545
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
545
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

67
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
67
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

82
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
82
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

90
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
90

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unmasking Essential Thrombocythemia in Heparin-Induced Thrombocytopenia After Coronary Artery Bypass Grafting.

JACC. Case reports·2026
Same author

Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT Study.

JACC. Heart failure·2026
Same author

Utility of Right Ventricular Mass Ratios in Recipients With Pulmonary Hypertension: A United Network for Organ-Sharing Database Analysis.

Clinical transplantation·2026
Same author

Longitudinal Peripheral Blood Transcriptomics Reveal Novel Signatures During Cardiac Allograft Rejection.

Transplantation direct·2026
Same author

Sex differences in the association of vascular risk and APOE Genotype with cognitive decline and dementia: evidence from a U.S. longitudinal study.

Lancet regional health. Americas·2026
Same author

The U.S. diabetes belt and factors explaining the excess risk: Multifactorial modeling and machine learning analysis.

Primary care diabetes·2025

Related Experiment Video

Updated: Sep 29, 2025

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

20.5K

Novel Immunosuppression in Solid Organ Transplantation.

Prasad Konda1, Reshma Golamari2, Howard J Eisen3

  • 1Heart and Vascular Institute, Pennsylvania State University/Milton S. Hershey Medical Center, Hershey, PA, USA.

Handbook of Experimental Pharmacology
|March 23, 2022
PubMed
Summary

Recent advancements in immunosuppression have significantly improved solid organ transplantation survival rates. This chapter explores novel immunosuppressive therapies, including mTOR inhibitors and rituximab, for induction, maintenance, and rejection treatment.

Keywords:
Heart transplantationImmunosuppression

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K
Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

6.2K

Related Experiment Videos

Last Updated: Sep 29, 2025

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

20.5K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K
Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

6.2K

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pharmacology

Background:

  • Solid organ transplantation survival has dramatically improved due to immunosuppression advancements.
  • Current strategies are shifting towards steroid-free regimens.
  • Novel immunosuppressive agents are crucial for managing transplantation phases.

Purpose of the Study:

  • To discuss newer immunosuppressive therapies for solid organ transplantation.
  • To highlight agents that mitigate side effects and reduce rejection.
  • To provide an overview of recent innovations in transplant immunosuppression.

Main Methods:

  • Review of current literature on immunosuppressive agents in solid organ transplantation.
  • Discussion of specific drug classes like mTOR inhibitors and monoclonal antibodies (e.g., rituximab).
  • Analysis of their roles in induction, maintenance, and acute rejection treatment.

Main Results:

  • mTOR inhibitors offer renal-sparing effects compared to calcineurin inhibitors.
  • Rituximab has shown efficacy in decreasing donor-specific antibodies and acute rejection.
  • Novel agents contribute to improved outcomes in various stages of transplantation.

Conclusions:

  • Newer immunosuppressive therapies are vital for enhancing solid organ transplant success.
  • Targeted agents like mTOR inhibitors and rituximab address specific challenges in transplantation.
  • The field continues to evolve with innovations aimed at improving patient survival and graft function.